Valion BioVBIO
13F holders, Q1 2026 (March 31)9holders +2
5new positions
3sold out
$0.88avg. 13F price*
At the end of Q1 2026, 9 institutions reported holding Valion Bio Inc. (VBIO) in their 13F filings, up 2 from Q4 2025. 5 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($78K), Sanctuary Advisors, LLC ($54K) and Marex Group Ltd ($52K).
- Company
- Valion Bio Inc.
- Filed as
- TIVIC HEALTH SYSTEMS INC (Q1 2026)
- CUSIP
- 888705308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $178K |
| Exits | 3 | $28K |
All 13F filers, Q4 2025 → Q1 2026: 220,270 shares bought and 38,007 shares sold, net +182,263 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Geode Capital Management, LLC | 0.00% | New | 87,818 | $78K |
| Sanctuary Advisors, LLC | 0.00% | New | 61,205 | $54K |
| Marex Group Ltd | 0.00% | Add +44.8% | 59,263 | $52K |
| HRT Financial LP | 0.00% | New | 42,419 | $37K |
| XTX Topco Ltd | 0.00% | New | 10,506 | $9K |
| UBS Group AG | 0.00% | Reduce -88.0% | 2,366 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -64.6% | 584 | $517 |
| SBI Securities Co., Ltd. | 0.00% | No change | 16 | $14 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is VBIO's weight in each manager's 13F, not the share of Valion Bio Inc. the manager owns.